SCHEMBL790373

SCHEMBL790373

O=c1[nH]c2ccc(I)cc2cc1Br

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 1/20 0.46
HRH4 Q9H3N8 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
NOS1 P29475 1/20 0.39
DAO P14920 4/20 0.39
MAPK1 P28482 2/20 0.38
IDH1 O75874 2/20 0.38
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
CHEK1 O14757 1/20 0.35
AURKA O14965 1/20 0.35
DAPK3 O43293 1/20 0.35
JAK2 O60674 1/20 0.35
PRKD3 O94806 1/20 0.35
MAP4K4 O95819 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18548573 0.81 CYP19A1 (0.49) PARGHRH4HRH3NOS1DAO
SCHEMBL31142836 0.78 DAO (0.46) HRH4HRH3NOS1DAOIDH1
SCHEMBL24970982 0.78 DAO (0.46) HRH4HRH3NOS1DAOIDH1
SCHEMBL31142960 0.78 DAO (0.64) PARGDAOPDGFRBPDGFRAFLT3
SCHEMBL31143054 0.78 DAO (0.64) PARGDAOIDH1GRIN2DGRIN3B
SCHEMBL24970981 0.78 DAO (0.64) PARGDAOPDGFRBPDGFRAFLT3
SCHEMBL19126568 0.78 DAO (0.64) PARGHRH4DAOFLT3CDK5
SCHEMBL10140668 0.78 DAO (0.64) PARGDAOIDH1GRIN2DGRIN3B
SCHEMBL5817414 0.76 IDH1 (0.47) HRH4HRH3MAPK1IDH1KDM4E
SCHEMBL1366008 0.75 KDM4E (0.48) HRH4HRH3NOS1DAOIDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012037108-A1 AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed
WO-2012037108-A1 AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed